國家衛生研究院 NHRI:Item 3990099045/10236
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 912216      線上人數 : 1179
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/10236


    題名: Human placenta-derived multipotent cells (PDMCs) protect against Klebsiella pneumoniae-induced pneunomia by enhancing polymorphonuclear granulocytes (PMN) functions
    作者: Wang, LT;Chao, YY;Lee, W;Huang, LY;Liu, KJ;Siu, LK;Yen, BL
    貢獻者: Institute of Cellular and Systems Medicine;Division of Infectious Diseases;National Institute of Cancer Research
    摘要: Human mesenchymal stem cells (MSCs) are multilineage somatic progenitors with strong immunomodulatory properties which have been well-demonstrated for T lymphocytes and dendritic cells/macrophages. However, interactions with neutrophils (polymorphonuclear granulocytes or PMNs)—the most abundant population of human leukocytes—are less well understood. Therefore, we investigated the interactions of human placenta-derived multipotent cells (PDMCs), a population of fetal-stage MSCs, with PMNs through in vitro studies and a mouse model of Klebsiella pneumoniae (KP)-induced pneumonia. KP is a highly virulent gram-negative bacterium and a leading cause of community- and hospital-acquired infections, especially pneumonia. We found that after co-culture with PDMCs, PMN expression of CD11b—a marker of activation—as well as phagocytosis of FITC- labeled KP was significantly increased. Moreover, PMN oxidative metabolism was significantly increased as well, which manifested as increased anti-bacterial activity and improved killing of KP. To ascertain the therapeutic efficacy of PDMCs on bacterial infections, we infected wild type mice with KP by intratracheal inoculation with subsequent intravenous administration of PDMCs. Surprisingly, while injection of PDMCs reduced the influx of PMNs in KP-infected lung tissue, respiratory burst activity was simultaneously enhanced. PDMC treatment also decreased bacterial counts both locally in lung tissue and systemically in the bloodstream. Most importantly, administration of PDMCs significantly increased survival rates in this mouse model of KP pneumonia. Taken together, we found that PDMCs enhance PMN functions in vitro and in vivo towards KP without increasing overall lung inflammatory damage. Our data strongly implicate a possible therapeutic role for PDMCs towards gram-negative bacterial infections.
    日期: 2016-08
    關聯: European Journal of Immunology. 2016 Aug;46(Suppl. 1):1242.
    Link to: http://dx.doi.org/10.1002/eji.201670200
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0014-2980&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000391563600009
    顯示於類別:[顏伶汝] 會議論文/會議摘要
    [蕭樑基] 會議論文/會議摘要
    [劉柯俊] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000391563600009.pdf130KbAdobe PDF477檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋